Tag Archives: Prof Olav Mella

Elevated autoantibodies found in CFS subgroup

Research highlights: β adrenergic and muscarinic acetylcholine receptor autoantibodies are elevated in a subset of patients with Chronic Fatigue Syndrome (CFS). Elevated autoantibodies in CFS correlate with elevated IgG1-3 subclass levels, thyreoperoxidase and ANA antibodies and T cell activation. In … Continue reading

Posted in News | Tagged , , , , , , , | Comments Off on Elevated autoantibodies found in CFS subgroup

Norwegian Rituximab trial update

The Norwegian multicenter Rituximab study begins The long-awaited Norwegian phase III study of Rituximab as a treatment for ME/CFS is now getting off the ground. The study is led by the oncologists Prof Olav Mella and Dr Øystein Fluge at … Continue reading

Posted in News | Tagged , , , , , | Comments Off on Norwegian Rituximab trial update